title: Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
abstract: The purpose of this study is to develop a thermoresponsive sustained release delivery system combining phytantriol cubosomes and poloxamer 407 (P407). P407 undergoes thermoreversible gelation, where it exists as a free-flowing liquid at low temperature and gels upon heating. However, this polymer has the major draw back of fast erosion in aqueous environments which needs to be addressed. Three different concentrations of P407 (12%, 15% and 17% (w/v)) were formulated with various additives (methyl cellulose (MC), dextran, carrageenan and Pluronic-R (25R4)). The rheological characteristics and in vitro stability were investigated. The sol-gel transition temperature of P407 was lowered in the presence of the phytantriol cubosomes. The addition of MC and dextran did not affect the sol-gel transition temperature whereas 25R4 increased the gelation temperature. No transition was observed for the carrageenan formulations. The presence of 25R4 allowed the development of formulations that were free flowing liquid at working temperature (22 °C), gelled at body temperature (37 °C) and had improved stability in an aqueous environment. Both rheological and in vitro stability studies suggested that cubosome-loaded 17% (w/v) P407 with 25R4 in 1:1 molar ratio may have a potential as sustained release delivery system.
authors.affiliation: School of Pharmacy, University of Otago, Dunedin, New Zealand.
authors.forename: Thunjiradasiree
authors.initials: T
authors.lastname: Kojarunchitt
authors.forename: Sarah
authors.initials: S
authors.lastname: Hook
authors.forename: Shakila
authors.initials: S
authors.lastname: Rizwan
authors.forename: Thomas
authors.initials: T
authors.lastname: Rades
authors.forename: Stefania
authors.initials: S
authors.lastname: Baldursdottir
mesh_terms: D003692:Delayed-Action Preparations; D004337:Drug Carriers / Q000737:chemistry*; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry; D005782:Gels; D008823:Micelles; D044367:Phase Transition; D020442:Poloxamer / Q000737:chemistry*; D012212:Rheology; D013678:Technology, Pharmaceutical / Q000379:methods*; D013696:Temperature; D014612:Vaccines / Q000008:administration & dosage; D014783:Viscosity
chemical_list: D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005079:Excipients; D005782:Gels; D008823:Micelles; D014612:Vaccines; D020442:Poloxamer